HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
United Kingdom Wellness Ad Complaints

Vitamin C COVID-19 'Cure' Claims Not Getting Past ASA

  • News

Executive Summary

UK advertising watchdog ASA reprimands Revival Drinks for social media posts which claimed its vitamin C supplement could cure COVID-19.

You may also be interested in...



UK Industry Welcomes Coronavirus Responsible Advertising Guidelines

UK industry association, PAGB, welcomes a clarification from the country's advertising standards authority on how consumer healthcare products should be advertised during the Covid-19 pandemic.

P&G Given Green Light To Offload Haliborange Supplements

P&G's decision to offload its Haliborange children's supplement line will not lead to reduced competition in the UK market, according to the regulator.

Light In The Dark For Troubled GNC As It Wins Trademark Dispute

GNC has won a long running dispute over the use of its "GNC Live Well" trademark in Europe after a challenge by Lithuanian pharmacy retailer Euroapotheca was rejected by the European General Court.

Table

View full table

Topics

Tags:
United Kingdom Wellness Ad Complaints
UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By